{
    "nctId": "NCT03022162",
    "briefTitle": "Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer",
    "officialTitle": "Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer : A Prospective Observational Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female, Neuropathic Pain",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Prevalence of Paclitaxel induced CIPN-related pain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histopathologically confirmed Primary breast cancer\n2. Patients who had received adjuvant chemotherapy with Paclitaxel and who have completed their Paclitaxel chemotherapy within the preceding 2 years i.e. between 1stAugust 2014 to 31st July 2016.\n\nExclusion Criteria:\n\n1. Age below 18 years\n2. On current Paclitaxel chemotherapy\n3. Patients with radiological evidence of bone metastases.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}